The code block below illustrates how one might use # and // as comments in your logic and calculations.
# Text can be put here to explain what the logic/calculation does and why.
if ([field1] = '1' and [field2] > 7,
// This comment can explain what the next line does.
[score] * [factor],
// Return '0' if the condition is False.
0
)
Working …
0% means
50% means
100% means
This value you provided is not a number. Please try again.
This value you provided is not an integer. Please try again.
The value entered is not a valid Vanderbilt Medical Record Number (i.e. 4- to 9-digit number, excluding leading zeros). Please try again.
The value you provided must be within the suggested range
The value you provided is outside the suggested range
This value is admissible, but you may wish to double check it.
The value entered must be a time value in the following format HH:MM within the range 00:00-23:59 (e.g., 04:32 or 23:19).
This field must be a 5 or 9 digit U.S. ZIP Code (like 94043). Please re-enter it now.
This field must be a 10 digit U.S. phone number (like 415 555 1212). Please re-enter it now.
This field must be a valid email address (like joe@user.com). Please re-enter it now.
The value you provided could not be validated because it does not follow the expected format. Please try again.
Required format:
DDyrucJTEo3AtXbFhWcoAxiSxEUykGwcqHt
22-012710 - Breastfeeding and Breast Cancer Screening Among Carriers of Pathogenic Variants in BRCA 1 and BRCA 2 and Other High Penetrance Genes: Knowledge and Perspectives
AAA
Dear participant,
Childbearing and nursing may impact approaches to breast cancer screening and prevention; however, little is known about whether women at increased risk of breast cancer receive information about this topic.
Researchers at the Mayo Clinic and McGill University are partnering with the nonprofit organization Facing Our Risk of Cancer Empowered (FORCE) on a survey of women who have inherited mutations in BRCA1, BRCA2 or other genes (including PALB2, ATM, CHEK2, and others) related to increased breast cancer risk. Although we invite all eligible women to participate in this study, we are particularly interested in understanding the needs of women who tested positive for an inherited mutation prior to becoming pregnant and how they made decisions about timing of pregnancy, breastfeeding, breast cancer screening, and risk-reducing surgery. Decisions related to these issues are complex, and for some topics, there has not been enough research for experts to make recommendations or provide evidence-based guidelines for women. For this reason, we want to learn about women's needs for information about how breastfeeding affects cancer risk and options related to breast cancer screening at reproductive ages.
If you agree to participate, you will be asked to complete this survey. No personal identifiable information will be recorded. You do not have to answer any questions you do not want to answer; just leave it blank and move on to the next question. The survey will take about 15 minutes of your time.
There are no known risks to you from taking part in this research study. This study will not make your health better. It is for the benefit of research.
Please understand your participation is voluntary, and you have the right to refuse participation at any time without penalty. Thank you for taking the time to complete this confidential survey. We will use survey responses to help identify gaps in knowledge, develop resources and design future research studies to improve safety and quality of life during reproductive years. Further, your responses will help establish the need for developing new methods for breast cancer screening that are safe, effective, and can be performed while women are pregnant or nursing.
If you have any questions about this research study, you can contact a member of our study team at FLAQHSCS@mayo.edu. If you have any concerns, complaints, or general questions about your rights as a participant, please contact the Mayo Clinic Institutional Review Board (IRB) to speak to someone independent of the research team at (507) 266-4000 or toll free at (866) 273-4681.
You have selected an option that triggers this survey to end right now.
To save your responses and end the survey, click the 'End Survey' button below. If you have selected the wrong option by accident and/or wish to return to the survey, click the 'Return and Edit Response' button.